🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 12-week, multicenter, randomized, double-blind, placebo-controlle...
Status
Terminated
Location
Phoenix
Start Date
2017-03-27
Trial ID
NCT03062540
Treatments Being Tested
This is a 12-week, multicenter, randomized, double-blind, placebo-controlle...
Status
Terminated
Location
Ashild Peters
Start Date
2019-03-07
Trial ID
NCT03841773
Treatments Being Tested
This is a Phase 2, randomized, parallel-group, double-blind, placebo-contro...
Status
Completed
Location
Accel Research-Birmingham Clinical Research Unit
Start Date
2022-08-18
Trial ID
NCT05472090
Treatments Being Tested
Very low dose (VLD) cyclobenzaprine at bedtime has shown promise as a treat...
Status
Completed
Location
PharmaNet, Inc.
Start Date
2013-06
Trial ID
NCT01889173
This is a Phase 3, open-label, extension trial designed to evaluate the lon...
Status
Completed
Location
Multiple Locations
Start Date
2015-08-04
Trial ID
NCT02589275
Treatments Being Tested
This was an open-label, extension trial designed to evaluate the long-term ...
Status
Completed
Location
Denver
Start Date
2013-12
Trial ID
NCT02015234
Treatments Being Tested
Evaluate the long-term safety of TNX-102 SL 5.6 mg taken daily at bedtime o...
Status
Completed
Location
Little Rock
Start Date
2018-04-19
Trial ID
NCT03508700
Treatments Being Tested
The use of low-dose CBP dosed nightly at bedtime for FM was supported by th...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02436096
Treatments Being Tested
The present trial is designed to assess the safety and efficacy of TNX-102 ...
Status
Terminated
Location
Multiple Locations
Start Date
2016-07-22
Trial ID
NCT02829814
Treatments Being Tested
This is a Phase 3, randomized, parallel-group, double-blind, placebo-contro...
Status
Completed
Location
Tonix Clinical Site
Start Date
2020-07-22
Trial ID
NCT04508621
Treatments Being Tested